America First Investment Advisors LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 97,902 shares of the financial services provider’s stock after acquiring an additional 2,122 shares during the quarter. CME Group comprises 4.8% of America First Investment Advisors LLC’s investment portfolio, making the stock its 11th biggest position. America First Investment Advisors LLC’s holdings in CME Group were worth $21,602,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of the business. Cypress Capital Group increased its stake in CME Group by 1.1% during the third quarter. Cypress Capital Group now owns 34,190 shares of the financial services provider’s stock worth $7,544,000 after acquiring an additional 373 shares during the last quarter. Primecap Management Co. CA grew its holdings in shares of CME Group by 3.3% during the 3rd quarter. Primecap Management Co. CA now owns 1,861,690 shares of the financial services provider’s stock worth $410,782,000 after purchasing an additional 58,647 shares during the period. Intech Investment Management LLC increased its position in shares of CME Group by 46.2% during the 3rd quarter. Intech Investment Management LLC now owns 22,830 shares of the financial services provider’s stock worth $5,037,000 after purchasing an additional 7,214 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its position in shares of CME Group by 2.6% during the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 278,127 shares of the financial services provider’s stock worth $61,369,000 after purchasing an additional 6,923 shares during the last quarter. Finally, Citizens Financial Group Inc. RI raised its holdings in CME Group by 9.4% in the 3rd quarter. Citizens Financial Group Inc. RI now owns 1,369 shares of the financial services provider’s stock valued at $302,000 after buying an additional 118 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently issued reports on CME shares. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. The Goldman Sachs Group boosted their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Piper Sandler raised their price target on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research note on Thursday, October 24th. Finally, Oppenheimer increased their target price on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $224.47.
CME Group Stock Down 0.7 %
Shares of NASDAQ:CME opened at $228.00 on Thursday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.74. The firm’s 50 day moving average price is $223.21 and its 200 day moving average price is $210.81. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market cap of $82.16 billion, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 5.30 and a beta of 0.55.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.25 EPS. As a group, equities research analysts predict that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is 48.37%.
Insiders Place Their Bets
In related news, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This trade represents a 12.01 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the sale, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock valued at $3,441,063 in the last ninety days. Insiders own 0.30% of the company’s stock.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- How to Invest in Blue Chip Stocks
- Lowe’s Stock Dip: Don’t Miss This Second-Chance Entry Point
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Tailwinds Drive Walmart Higher, Uptrend Shows No Signs of Slowing
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Is Biotech’s Bull Run Over? Examining Election Impacts
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.